Santa Monica Partners LP purchased a new position in shares of Simulations Plus, Inc. (NASDAQ:SLP) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 33,063 shares of the technology company’s stock, valued at approximately $532,000. Simulations Plus comprises about 0.5% of Santa Monica Partners LP’s holdings, making the stock its 19th largest holding. Santa Monica Partners LP owned 0.19% of Simulations Plus at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently modified their holdings of SLP. Bank of Montreal Can bought a new position in Simulations Plus during the fourth quarter worth about $104,000. The Manufacturers Life Insurance Company grew its stake in Simulations Plus by 13.8% during the second quarter. The Manufacturers Life Insurance Company now owns 8,923 shares of the technology company’s stock worth $110,000 after buying an additional 1,085 shares in the last quarter. New York State Common Retirement Fund acquired a new stake in Simulations Plus during the second quarter worth about $143,000. Strs Ohio grew its stake in Simulations Plus by 196.9% during the fourth quarter. Strs Ohio now owns 9,500 shares of the technology company’s stock worth $152,000 after buying an additional 6,300 shares in the last quarter. Finally, Algert Global LLC acquired a new stake in shares of Simulations Plus in the 4th quarter valued at approximately $175,000. Hedge funds and other institutional investors own 33.93% of the company’s stock.
In related news, Chairman Walter S. Woltosz sold 18,500 shares of Simulations Plus stock in a transaction that occurred on Wednesday, December 27th. The stock was sold at an average price of $16.25, for a total transaction of $300,625.00. Following the sale, the chairman now owns 5,502,416 shares of the company’s stock, valued at approximately $89,414,260. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold a total of 55,500 shares of company stock worth $899,655 in the last three months. 33.45% of the stock is owned by corporate insiders.
A number of research analysts recently issued reports on the stock. Zacks Investment Research lowered shares of Simulations Plus from a “hold” rating to a “sell” rating in a report on Friday, December 22nd. BidaskClub upgraded shares of Simulations Plus from a “hold” rating to a “buy” rating in a research note on Saturday, February 24th.
Shares of SLP stock opened at $15.85 on Wednesday. The firm has a market capitalization of $279.28, a P/E ratio of 44.86 and a beta of -0.63. Simulations Plus, Inc. has a 52 week low of $10.35 and a 52 week high of $17.45.
Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Tuesday, January 9th. The technology company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. The business had revenue of $7.07 million during the quarter, compared to the consensus estimate of $6.57 million. Simulations Plus had a return on equity of 24.56% and a net margin of 23.78%. analysts anticipate that Simulations Plus, Inc. will post 0.4 earnings per share for the current fiscal year.
WARNING: “Santa Monica Partners LP Buys Shares of 33,063 Simulations Plus, Inc. (NASDAQ:SLP)” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2018/03/21/santa-monica-partners-lp-invests-532000-in-simulations-plus-inc-slp.html.
Simulations Plus Profile
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.